Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anthelminthic Agents

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Drugs that Destabilize Microtubules

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Flavokawain A: A Natural MAO-A Inhibitor With Therapeutic Promise for Depression.

Chemistry & biodiversity·2025

Same author

Green analytical method development and validation for Flavokawain A using RP-HPLC in bulk and in-house tablet dosage forms.

Annales pharmaceutiques francaises·2025

Same author

Repurposing clonixin and flunixin as anti-fibrotic candidates: Computational and preclinical evaluation in bleomycin-induced pulmonary fibrosis in rats.

Research in veterinary science·2025

Same author

Quinazoline-based fourth-generation EGFR tyrosine kinase inhibitors to overcome C797S-mediated resistance in non-small cell lung Cancer (NSCLC).

Bioorganic chemistry·2025

Same author

Lazertinib: A Cardio-Safer Alternative to Osimertinib for Epidermal Growth Factor Receptor L858R/T790M Double-Mutant Tyrosine Kinase Resistant Non-Small Cell Lung Cancer.

Drug development research·2025

Same author

Overcoming triple mutant EGFR-tyrosine kinase barriers in the therapeutics of non-small cell lung cancer: a patent review on fourth-generation inhibitors (2017-2024).

Expert opinion on therapeutic patents·2025

Search research articles

Related Experiment Video

Updated: May 21, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Benzothiazoles: search for anticancer agents.

Malleshappa N Noolvi¹, Harun M Patel, Manpreet Kaur

¹Department of Pharmaceutical Chemistry, Shree Dhanvantary Pharmacy College, Kim (Surat)-3941110, Gujrat, India. mnoolvi@yahoo.co.uk

European Journal of Medicinal Chemistry

|June 19, 2012

Summary

This summary is machine-generated.

Novel 2-amino benzothiazole derivatives were synthesized and screened for antitumor properties. Compound 4i demonstrated significant anticancer activity against Non-Small Cell Lung Cancer, warranting further investigation as a potential EGFR inhibitor.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Related Experiment Videos

Last Updated: May 21, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Area of Science:

Medicinal Chemistry
Oncology
Computational Chemistry

Background:

Benzothiazole derivatives are recognized for their diverse biological activities.
Anticancer drug discovery requires novel chemical scaffolds.
Targeting epidermal growth factor receptor (EGFR) is a key strategy in cancer therapy.

Purpose of the Study:

To synthesize and evaluate novel 2-amino benzothiazole derivatives for antitumor activity.
To identify potent anticancer agents from the synthesized series.
To explore the potential of these compounds as EGFR inhibitors through virtual screening.

Main Methods:

Chemical synthesis of 2-amino benzothiazole derivatives (4a-j).
Antitumor screening using the National Cancer Institute (NCI) 60 cell panel.
In silico molecular docking into the ATP binding site of EGFR.

Main Results:

Two synthesized compounds were selected for further NCI screening.
Compound 7-chloro-N-(2,6-dichlorophenyl)benzo[d]thiazol-2-amine (4i) exhibited potent activity with GI(50) = 7.18 × 10(-8) M against HOP-92 Non-Small Cell Lung Cancer cells.
Docking studies suggested a potential binding mode analogous to known EGFR inhibitors.

Conclusions:

Compound 4i is a highly promising anticancer agent, particularly for Non-Small Cell Lung Cancer.
The synthesized benzothiazole derivatives show potential as EGFR inhibitors.
Further preclinical studies are warranted to validate the efficacy and mechanism of action of compound 4i.